Furthermore, we reported that high p53 immunostaining correlated with lower tumor differentiation when analyzing the entire NSCLC cohort; however, when we analyzed the adenocarcinoma and squamous cell carcinoma patient subsets independently, we observed that this correlation between p53 and tumor differentiation was only maintained in squamous cell carcinoma. The gene discussed is TP53; the disease is neoplasm.